TRAVATAN Z® and Other Prostaglandin Analog Drugs
`
`EXHIBIT 2052
`
`90%
`
`80%
`
`70%
`
`60%
`
`50%
`
`40%
`
`30%
`
`Share of Voice Including Retail Value of Samples 100%
`
`20%
`
`10%
`
`0%
`
`10.1%
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`2012
`
`2013
`
`mTRAVATAN Z®
`
`mTRAVATAN®
`
`sg LUMIGAN®
`
`BZIOPTAN™
`
`BXALATAN®
`
`mRESCULA®
`
`Source: Encuity
`Note: Share of voice is calculated as promotional spending including retail value of samples of each drug over combined promotional spending including retail
`value of samplesfor all drugs in the therapeutic category. Data on retail value of samples are not available for 2006. TRAVATAN Z® was launchedin October
`2006.
`
`CONFIDENTIAL-PROTECTIVE ORDER MATERIAL
`
`ALCON 2052
`Argentum Pharm. LLC v. Alcon Research, Ltd.
`Case IPR2017-01053
`
`
Still Working On It
This document is taking longer than usual to download. This can
happen if we need to contact the court directly to obtain the
document and their servers are running slowly.
Give it another minute or two to complete, and then try the
refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
One Moment Please
The filing “”
is large (MB) and is being
downloaded.
Please refresh this page in a few minutes to see if the
filing has been downloaded. The filing will also be emailed
to you when the download completes.
Sealed Document
We are unable to display this document, it may be under a court
ordered seal.
If you have proper credentials to access the file, you may proceed
directly to the court's system using your government issued username
and password.
Access Government Site